Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
First-in-Human, Phase I Dose-Escalation and Dose-Expansion Study of Trophoblast Cell-Surface Antigen 2–Directed Antibody-Drug Conjugate Datopotamab Deruxtecan in Non–Small-Cell Lung Cancer: TROPION-PanTumor01
PaperCitations, authors & open-access status
First-in-Human, Phase I Dose-Escalation and Dose-Expansion Study of Trophoblast Cell-Surface Antigen 2–Directed Antibody-Drug Conjugate Datopotamab Deruxtecan in Non–Small-Cell Lung Cancer: TROPION-PanTumor01 is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 178 citations, 2023 year and hybrid oa status.
178
Citations
2023
Year
hybrid
OA Status